TransCode Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.About RNAZ
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
RNAZ Key Statistics
Stock Snapshot
TransCode Therapeutics(RNAZ) stock is priced at $9.63, giving the company a market capitalization of 8.83M. It carries a P/E multiple of -0.04.
On 2026-03-18, TransCode Therapeutics(RNAZ) stock traded between a low of $9.18 and a high of $9.28. Shares are currently priced at $9.63, which is +4.9% above the low and +3.8% below the high.
The TransCode Therapeutics(RNAZ)'s current trading volume is 3.67K, compared to an average daily volume of 10.98K.
In the last year, TransCode Therapeutics(RNAZ) shares hit a 52-week high of $46.76 and a 52-week low of $6.08.
In the last year, TransCode Therapeutics(RNAZ) shares hit a 52-week high of $46.76 and a 52-week low of $6.08.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.